Parnax Lab Stock Screener | Share Price & Fundamental Analysis
PARNAXLAB
Pharmaceuticals
Screen Parnax Lab share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹125.15
▼
-1.05 (-0.83%)
Market Cap
₹150.55 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.60
EPS (TTM)
₹10.03
Dividend Yield
-
Debt to Equity
0.97
52W High
₹164.05
52W Low
₹84.04
Operating Margin
13.00%
Profit Margin
6.35%
Revenue (TTM)
₹63.00
EBITDA
₹9.00
Net Income
₹4.00
Total Assets
₹190.00
Total Equity
₹83.00
Parnax Lab Share Price History - Stock Screener Chart
Screen PARNAXLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Parnax Lab Company Profile - Fundamental Screener
Screen Parnax Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PARNAXLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE383L01019
Parnax Lab Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen PARNAXLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 190 | 190 | 145 | 154 | 106 | 107 | 95 | 87 | 86 | 79 |
| Current Assets | 65 | 73 | 57 | 71 | 39 | 46 | 37 | 37 | 31 | 31 |
| Fixed Assets | 88 | 90 | 77 | 72 | 60 | 58 | 51 | 44 | 47 | 38 |
| Liabilities | ||||||||||
| Total Liabilities | 190 | 190 | 145 | 154 | 106 | 107 | 95 | 87 | 86 | 79 |
| Current Liabilities | 32 | 35 | 20 | 24 | 19 | 22 | 23 | 18 | 18 | 23 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 83 | 72 | 62 | 48 | 33 | 33 | 36 | 33 | 31 | 28 |
| Share Capital | 12 | 12 | 12 | 10 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 72 | 60 | 51 | 37 | 24 | 24 | 27 | 24 | 23 | 19 |
Screen PARNAXLAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 63 | 54 | 50 | 40 | 49 | 50 | 47 | 41 | 49 | 43 | 51 | 48 | 37 | 43 | 47 |
| Expenses | 55 | 46 | 42 | 36 | 41 | 42 | 41 | 36 | 42 | 37 | 45 | 41 | 31 | 38 | 40 |
| EBITDA | 9 | 8 | 7 | 5 | 8 | 9 | 6 | 5 | 7 | 6 | 6 | 7 | 5 | 6 | 7 |
| Operating Profit % | 13.00% | 14.00% | 14.00% | 11.00% | 15.00% | 17.00% | 13.00% | 12.00% | 13.00% | 12.00% | 12.00% | 15.00% | 14.00% | 13.00% | 16.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 5 | 5 | 4 | 2 | 5 | 5 | 3 | 2 | 4 | 2 | 3 | 4 | 3 | 3 | 4 |
| Tax | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 1 | 1 |
| Net Profit | 4 | 3 | 3 | 1 | 3 | 4 | 2 | 1 | 3 | 2 | 2 | 0 | 2 | 2 | 3 |
| EPS | 3.15 | 2.85 | 2.55 | 1.06 | 2.97 | 3.47 | 1.95 | 1.30 | 2.90 | 1.63 | 1.90 | -0.18 | 1.97 | 1.83 | 2.96 |
Parnax Lab Cash Flow Screener - Liquidity Fundamentals
Screen PARNAXLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 32 | 16 | 21 | 9 | 6 | 9 | 9 | 13 | 16 | 4 |
| Investing Activities | -16 | -32 | -10 | -17 | -7 | -13 | -11 | -5 | -10 | -6 |
| Financing Activities | -16 | 15 | -14 | 12 | 0 | 5 | 1 | -7 | -5 | 1 |
| Net Cash Flow | 0 | -1 | -3 | 4 | 0 | 0 | -1 | 1 | 0 | -2 |
Screen PARNAXLAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.93% | 24.97% | 24.73% | 24.68% | 24.26% | 24.60% | 24.45% | 24.59% |
| Other Holding | 2.77% | 2.74% | 2.97% | 3.02% | 3.44% | 3.11% | 3.26% | 3.11% |
| Shareholder Count | 4,111 | 4,317 | 4,440 | 4,521 | 4,173 | 4,406 | 4,496 | 3,060 |
Parnax Lab Dividend Screener - Share Yield Analysis
Screen PARNAXLAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Parnax Lab Index Membership - Market Screener Classification
Screen PARNAXLAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Parnax Lab Market Events Screener - Corporate Actions
Screen PARNAXLAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 2.57% | ||
| Annual General Meeting | NA | 1.00% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.58% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -2.47% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | -4.44% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 2.05% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 0.33% |
Parnax Lab Competitors Screener - Peer Comparison
Screen PARNAXLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 423,003 | 39.93 | 54,729 | 9.71% | 10,980 | 42.57 |
| Divis Laboratories | 173,112 | 69.20 | 9,712 | 18.67% | 2,191 | 54.31 |
| Torrent Pharmaceuticals | 129,185 | 60.10 | 11,539 | 6.99% | 1,911 | 59.28 |
| Cipla | 122,011 | 22.55 | 28,410 | 7.12% | 5,291 | 51.13 |
| Dr Reddys Laboratories | 107,014 | 18.60 | 33,741 | 16.73% | 5,725 | 57.95 |
| Lupin | 97,019 | 22.34 | 22,910 | 13.74% | 3,306 | 65.19 |
| Zydus Life Science | 92,926 | 18.40 | 23,511 | 18.55% | 4,615 | 40.83 |
| Mankind Pharma | 89,969 | 50.59 | 12,744 | 20.90% | 2,007 | 42.47 |
| Aurobindo Pharma | 71,578 | 20.79 | 32,346 | 9.43% | 3,484 | 60.10 |
| Alkem Laboratories | 67,249 | 27.59 | 13,458 | 3.70% | 2,216 | 43.27 |
Parnax Lab Company Announcements - News Screener
Screen PARNAXLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-14 | Results For The Quarter Ended September 30 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th November 2025 | View |
| 2025-11-03 | Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited IND- AS Compliant Financial Results Along With Limited Review Report For The Quarter (Q2) And Half Year Ended 30Th September 2025. | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-29 | Appointment Of HSPN Associates & LLP As Secretarial Auditor Of The Company. | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-06 | Notice Of 43Rd Annual General Meeting Schedule To Be Held On Monday 29Th September 2025. | View |
| 2025-08-29 | Corporate Action- Fixes Book Closure For Annual General Meeting. | View |
| 2025-08-13 | Intimation Of Appointment Of Secretarial Auditor Under Regulation 24(A) And Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (As Amended). | View |
| 2025-08-13 | Financial Results For The Quarter Ended June 30 2025. | View |
| 2025-08-13 | Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Standalone And Consolidated Unaudited Results For The Quarter Ended June 30 2025. | View |
| 2025-08-05 | Board Meeting Intimation for For The Quarter Ended June 30 2025 | View |
| 2025-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-06-27 | Closure of Trading Window | View |
| 2025-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | View |
| 2025-05-27 | Financial Results For The Quarter And Year Ended March 31 2025. | View |